资源受限地区新生儿高胆红素血症的监测管理

Chinese Journal of Child Health Care ›› 2016, Vol. 24 ›› Issue (8) : 838-841.

PDF(505 KB)
PDF(505 KB)
Chinese Journal of Child Health Care ›› 2016, Vol. 24 ›› Issue (8) : 838-841. DOI: 10.11852/zgetbjzz2016-24-08-16

Author information +
History +

Cite this article

Download Citations

References

[1] Ezeaka CV,Ugwu RO,Mukhtar-Yola M,et al.Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria:a multi-centre survey[J].BMC Health Services Research,2014,14:192-198.
[2] Mwaniki MK,Atieno M,Lawn JE,et al.Long-term neurodevelopmental outcomes after intrauterine and neonatal insults:a systematic review[J].Lancet,2012,379:445-452.
[3] Bhutani VK,Zipursky A,Blencowe H,et al.Neonatal hyperbilirubinemia and Rhesus disease of the newborn:incidence and impairment estimates for 2010 at regional and global levels[J].Pediatr Res,2013,74(Suppl 1):86-100.
[4] Lawn JE,Blencowe H,Oza S,et al.Lancet every newborn study group.every newborn:progress,priorities,and potential beyond survival[J].Lancet,2014,384:189-205.
[5] Iskander I,Gamaleldin R,Kabbani M.Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt[J].East Mediterr Health J,2012,8:882-887.
[6] Olusanya BO,Ogunlesi TA,Slusher TM.Why is kernicterus still a major cause of death and disability in low and middle-income countries?[J].Arch Dis Child,2014,99:1117-1121.
[7] Cline BK,Vreman HJ,Faber K,et al.Phototherapy device effectiveness in Nigeria:irradiance assessment and potential for improvement[J].J Trop Pediatr,2013,59:321-325.
[8] Olusanya BO,Emokpae AA,Zamora TG,et al.Addressing the burden of severe neonatal hyperbilirubinaemia in low and middle-income countries with significant G6PD-deficiency[J].Acta Paediatr,2014,103:1102-1109.
[9] Khassawneh M,Rubaie Z,Khashashneh I,et al.Adherence with American Academy of Pediatrics guidelines when managing neonatal jaundice in Jordan[J].Res Rep Neonatol,2013,3:27-31.
[10] Radmacher PG,Groves FD,Owa JA,et al.A modified bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting[J].BMC Pediatrics,2015,15:28-39.
[11] Rylance S,Yan J,Molyneux E.Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi?[J].Paediatr Int Child Health,2014,34:101-107.
[12] Akahira-Azuma M,Yonemoto N,Ganzorig B,et al.Validation of a transcutaneous bilirubin meter in Mongolian neonates:comparison with total serum bilirubin[J].BMC Pediatr,2013,13:151-159.
[13] O'Connor MC,Lease MA,Whalen BL.How to use:transcutaneous bilirubinometry[J].Arch Dis Child Educ Pract Ed,2013,98:154-159.
[14] Coda Zabetta CD,Iskander IF,Greco C,et al.Bilistick:a low-cost point-of-care system to measure total plasma bilirubin[J].Neonatology,2013,103:177-181.
[15] Dijk PH,Hulzebos CV.An evidence-based view on hyperbilirubinaemia[J].Acta Paediatr Suppl,2012,101:3-10.
[16] Tridente A,De Luca D.Efficacy of light-emitting diode versus other light sources for treatment of neonatal hyperbilirubinemia:a systematic review and meta-analysis[J].Acta Paediatr,2012,101:458-465.
[17] Okperi BO.Neonatal jaundice and birth asphyxia as major causes of cerebral palsy in Nigeria:are doctors' wrong beliefs and practices part of the problem?[J] Int J Med Biomed Res,2013,2:226-230.
[18] Slusher TM,Vreman HJ,Olusanya BO,et al.Safety and efficacy of filtered sunlight in treatment of jaundice in African neonates.Pediatrics,2014,133:568-574.
[19] Slusher TM,Olusanya BO,Vreman HJ,et al.Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates:study protocol of a non-inferiority,randomized controlled trial[J].Trials,2013,14:446-451.
[20] Ibekwe RC,Ibekwe MU,Muoneke VU.Outcome of exchange blood transfusions done for neonatal jaundice in Abakaliki,South eastern Nigeria[J].J Clin Neonatol,2012,1:34-37.
[21] Egube BA,Ofili AN,Isara AR,et al.Neonatal jaundice and its management:knowledge,attitude,and practice among expectant mothers attending antenatal clinic at University of Benin Teaching Hospital,Benin City,Nigeria[J].Niger J Clin Pract,2013,16:188-194.
[22] Schulz S,Wong RJ,Vreman HJ,et al.Metalloporphyrins - an update[J].Front Pharmacol,2012,3:68-73.
[23] Yousafzai AK,Lynch P,Gladstone M.Moving beyond prevalence studies:screening and interventions for children with disabilities in low-income and middle-income countries[J].Arch Dis Child,2014,99:840-848.
[24] Haroon M,Ranmal R,McElroy H,et al.On behalf of the royal college of paediatrics and child health clinical standards committee.developing clinical guidelines:how much rigour is required?[J] Arch Dis Child Educ Pract Ed,2015,100:89-96.
PDF(505 KB)

Accesses

Citation

Detail

Sections
Recommended

/